No Data
Express News | Needham Reiterates Buy on Blueprint Medicines, Maintains $133 Price Target
Pharma Stocks Have Risk of U.S. Tariffs Priced In -- Market Talk
The "Liberation Day" of Trump's tariffs is approaching, and the pharmaceutical Industry may not be among the targets.
According to reports, President Trump of the USA is expected to announce a series of broader tariff measures on local time April 2 (Wednesday), which will not include any specific details on Pharmaceutical tariffs.
Wolfe Research Maintains Blueprint Medicines(BPMC.US) With Buy Rating, Maintains Target Price $132
Blueprint Medicines to Present at 24th Annual Needham Virtual Healthcare Conference
Blueprint Medicines Corporation's (NASDAQ:BPMC) Shift From Loss To Profit
